Arkadios Wealth Advisors Autolus Therapeutics PLC Transaction History
Arkadios Wealth Advisors
- $1.71 Billion
- Q4 2024
A detailed history of Arkadios Wealth Advisors transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Arkadios Wealth Advisors holds 20,000 shares of AUTL stock, worth $46,600. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$46,600% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding AUTL
# of Institutions
109Shares Held
163MCall Options Held
2.8KPut Options Held
13.4K-
Wellington Management Group LLP Boston, MA24.2MShares$56.4 Million0.02% of portfolio
-
Blackstone Inc New York, NY20.5MShares$47.7 Million0.35% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X018.6MShares$43.2 Million83.42% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$35.6 Million2.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$28.8 Million0.67% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $212M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...